Scilex Holding Company Increase (Decrease) in Notes Payable, Related Parties, Current
Scilex Holding Company (SCLX) reported Increase (Decrease) in Notes Payable, Related Parties, Current of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesPayableRelatedPartiesCurrent · last filed 2024-03-12
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for the quarter ending 2023-09-30 was -$1.04M, a 108.17% decline year-over-year.
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for the quarter ending 2023-06-30 was $1.04M, a 79.32% decline year-over-year.
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for fiscal 2022 was $30.13M, a 65.43% increase from fiscal 2021.
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for fiscal 2021 was $18.21M, a 256.71% increase from fiscal 2020.
- Scilex Holding Company increase (decrease) in notes payable, related parties, current for fiscal 2020 was $5.11M.
| Period end | Increase (Decrease) in Notes Payable, Related Parties, Current 3 month | Increase (Decrease) in Notes Payable, Related Parties, Current 6 month | Increase (Decrease) in Notes Payable, Related Parties, Current 9 month | Increase (Decrease) in Notes Payable, Related Parties, Current 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$1.04M derived: sum of 2 quarters · filed 2024-03-12 | $0.00 derived: sum of 3 quarters · filed 2024-03-12 | $0.00 10-K · filed 2024-03-12 |
| 2023-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $8.60M derived: sum of 4 quarters · filed 2024-03-12 |
| 2023-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.04M 10-Q · filed 2023-08-11 | $9.65M derived: sum of 3 quarters · filed 2024-03-12 | $22.41M derived: sum of 4 quarters · filed 2024-03-12 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 | $8.60M derived: sum of 2 quarters · filed 2024-03-12 | $21.37M derived: sum of 3 quarters · filed 2024-03-12 | $26.41M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $21.37M derived: sum of 2 quarters · filed 2024-03-12 | $26.41M derived: sum of 3 quarters · filed 2024-03-12 | $30.13M 10-K · filed 2024-03-12 |
| 2022-09-30 | $12.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $17.81M derived: sum of 2 quarters · filed 2023-11-14 | $21.52M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $8.76M 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | $3.71M 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | $18.21M 10-K · filed 2024-03-12 | |||
| 2020-12-31 | $5.11M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |